Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 20, 2011 - Issue 12
Submit an article Journal homepage
128
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Identification of heptapeptides interacting with IFN-α-sensitive CML cells

Jia Liu Department of Biochemistry, School of Biological Science and Technology, Central South University, Changsha, 410013, Hunan, [email protected]
,
Han-chun Chen Department of Biochemistry, School of Biological Science and Technology, Central South University, Changsha, 410013, Hunan, [email protected]
,
Zhou-zhou Rao Department of Gynecology and Obstetrics, the Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China
,
Md. Asaduzzaman Khan Department of Biochemistry, School of Biological Science and Technology, Central South University, Changsha, 410013, Hunan, [email protected]
,
Xin-xing Wan Department of Biochemistry, School of Biological Science and Technology, Central South University, Changsha, 410013, Hunan, [email protected]
,
Ai-hua Xu Department of Biochemistry, School of Biological Science and Technology, Central South University, Changsha, 410013, Hunan, [email protected]
,
Nuo Zhang Department of Biochemistry, School of Biological Science and Technology, Central South University, Changsha, 410013, Hunan, [email protected]
&
Dian-zheng Zhang Department of Biochemistry, School of Biological Science and Technology, Central South University, Changsha, 410013, Hunan, [email protected]; Department of Biochemistry/Molecular Biology, Philadelphia College of Osteopathic Medicine, Philadelphia, PA 19131, USA
 show all
Pages 1583-1589 | Published online: 18 Nov 2011

Bibliography

  • Faderl S, Talpaz M, Estrov Z, Chronic myelogenous leukemia: biology and therapy. Ann Intern Med 1999;20:207-19
  • Quintas-Cardama A, Cortes J. Molecular biology of bcr-abl1–positive chronic myeloid leukemia. Blood 2009;113:1619-30
  • Zhou LL, Zhao Y, Ringrose A, AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells. J Exp Med 2008;205:2657-71
  • Preudhomme C, Guilhot J, Nicolini FE, Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia. N Engl J Med 2010;363:2511-21
  • Hehlmann R, Hochhaus A, Baccarani M. European leukemia net. Chronic myeloid leukaemia. Lancet 2007;370:342-50
  • Yanagisawa K, Yamauchi H, Kaneko M, Suppression of cell proliferation and the expression of a bcr-abl fusion gene and apoptotic cell death in a new human chronic myelogenous leukemia cell line, KT-1, by interferon-alpha. Blood 1998;91:641-8
  • Bekisz J, Baron S, Balinsky C, Antiproliferative properties of type I and type II interferon. Pharmaceuticals (Basel) 2010;3:994-1015
  • Simonsson B, Hjorth-Hansen H, Bjerrum OW, Interferon alpha for treatment of chronic myeloid leukemia. Curr Drug Targets 2011;12:420-8
  • Kreutzman A, Rohon P, Faber E, Chronic myeloid leukemia patients in prolonged remission following interferon-alpha monotherapy have distinct cytokine and oligoclonal lymphocyte profile. PLoS ONE 2011;6:e23022
  • Paquette RL, Hsu N, Said J, Interferon-alpha induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo. Leukemia 2002;16:1484-9
  • Li XM, Chen HC, Liu XF, Different sensitivity of two chronic myeloid leukemia cell lines to interferon-alpha. Ai Zheng (Chinese) 2003;22:1047-52
  • Yamauchi H, Sakai I, Narumi H, Development of interferon-alpha resistant subline from human chronic myelogenous leukemia cell line KT-1. Intern Med 2001;40:607-12
  • Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985;228:1315-17
  • Lunder M, Bratkovic T, Doljak B, Comparison of bacterial and phage display peptide libraries in search of target-binding motif. Appl Biochem Biotechnol 2005;127:125-31
  • Bratkovic T, Lunder M, Popovic T, Affinity selection to papain yields potent peptide inhibitors of cathepsins L, B, H, and K. Biochem Biophys Res Commun 2005;332:897-903
  • Yu L, Yu PS, Yee Yen Mui E, Phage display screening against a set of targets to establish peptide-based sugar mimetics and molecular docking to predict binding site. Bioorg Med Chem 2009;7:4825-32
  • Bakker AB, van den Oudenrijn S, Bakker AQ, C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia. Cancer Res 2004;64:8443-50
  • Lee SM, Lee EJ, Hong HY, Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display. Mol Cancer Res 2007;5:11-19
  • Kozbor D. Cancer vaccine with mimotopes of tumor-associated carbohydrate antigens. Immunol Res 2010;46:23-31
  • Du B, Han H, Wang Z, Targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding peptide. Mol Cancer Res 2010;8:135-44
  • Ladner RC, Sato AK, Gorzelany J, Phage display-derived peptides as therapeutic alternatives to antibodies. Drug Discov Today 2004;9:525-9
  • Alexopoulou L, Holt AC, Medzhitov R, Recognition of double-stranded RNA and activation of NF-kappa B by Toll-like receptor 3. Nature 2001;413:732-8
  • Roskoski R Jr. Structure and regulation of Kit protein-tyrosine kinase–the stem cell factor receptor. Biochem Biophys Res Commun 2005;338:1307-15
  • Heisterkamp N, Groffen J, Warburton D, The human gamma-glutamyltransferase gene family. Hum Genet 2008;123:321-32
  • Yang Y, Yu X. Regulation of apoptosis: the ubiquitous way. FASEB J 2003;17:790-9
  • Huang J, Xu LG, Liu T, The p53-inducible E3 ubiquitin ligase p53RFP induces p53-dependent apoptosis. FEBS Lett 2006;580:940-7
  • Zhang B, Huang J, Li HL, GIDE is a mitochondrial E3 ubiquitin ligase that induces apoptosis and slows growth. Cell Res 2008;18:900-10
  • Yang W, El-Deiry WS. CARPs are E3 ligases that target apical caspases and p53. Cancer Biol Ther 2007;6:1676-83
  • Makishima H, Cazzolli H, Szpurka H, Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies. J Clin Oncol 2009;27:6109-16
  • Zhao C, Hsiang TY, Kuo RL, ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc Natl Acad Sci USA 2010;107:2253-8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.